# Samra Turajlic

Топ епизоди на подкаста
Актуализирано:

Current biomarkers in immunotherapy

Immunotherapy approaches have revolutionized medical oncology in the last years. However, still only a fraction of patients is responding. Given the risk of side effects without efficacy, therefore, biomarkers providing reliable and reproducible prediction of response are urgently needed. In this p…

Genetics Shambles 5: The evolution of cancer

Cancer is the second leading cause of death in humans globally. But the catch all term of ‘cancer’ is often misunderstood. So what exactly is this cell disease that impacts so many of our lives? How long has it been around? How does it spread? What is our current understanding of its evolution and …

Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.

Episode 94: EIKCS Summary of Day 1

Samra Turajlic summarised the meetings and looks forward to Day 2...